Hereditary blood disorder found in South-East Asia, South-West Pacific could offer clues for malaria vaccine

NewsGuard 100/100 Score

"A team of international scientists has found that a type of hereditary disorder in some communities in South-East Asia and the South-West Pacific protects its sufferers from malaria, a finding that could drive future vaccine design," SciDev.Net reports. "Southeast Asian Ovalocytosis (SAO), an inherited disorder in which red blood cells are oval, instead of round, could be a unique human adaptation to resist malaria, according to a paper published in PLoS Medicine this month," the news service writes.

"The mechanism by which SAO protects against malaria is unknown," but "the oval shape of the blood cells could make it harder for the malaria parasite to attach and enter the red blood cells of its host," according to SciDev.Net. "The lead researcher, Ivo Mueller from the Walter and Eliza Hall Institute in Australia, and his team hope to find out which protein the parasite uses to bind to SAO cells," the news service notes, adding, "If this protein is found, it could be used to develop a malaria vaccine, a goal that has long eluded researchers" (Rochmyaningsih, 9/17).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ChatGPT could be an effective tool to help reduce vaccine hesitancy